Baker Brothers Advisors - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is and the CUSIP is 483119202. A total of 29 filers reported holding KALA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,372,856
+39.9%
266,613
+129.4%
0.01%
+40.0%
Q2 2023$1,695,548
+46.7%
116,213
+51.3%
0.01%
+66.7%
Q1 2023$1,156,036
-60.6%
76,8130.0%0.01%
-66.7%
Q4 2022$2,930,41676,8130.02%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Board of Trustees of The Leland Stanford Junior University 11,379$434,1080.04%
CLEAR STREET LLC 49,390$1,8840.02%
Baker Brothers Advisors 76,813$2,930,4160.02%
Knights of Columbus Asset Advisors LLC 2,417$92,2090.01%
TWO SIGMA SECURITIES, LLC 6,517$248,6240.01%
Covestor Ltd 440$160.01%
Banque Cantonale Vaudoise 1,508$580.00%
MILLENNIUM MANAGEMENT LLC 75,696$2,8880.00%
Renaissance Technologies 10,592$4040.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 53,100$2,025,7650.00%
View complete list of KALA PHARMACEUTICALS INC shareholders